Clin2
NCT07878481Likely a fitNot yet recruiting

Study of a new oral drug for healthy volunteers

SafetyTolerabilityPharmacokinetic

This trial tests a new oral medication in healthy adults to see how safe it is and how the body handles it. It's an early-stage study, so participants help determine the right dose for future patients.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
64 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You must be 18 to 60 years old.
  • Your body mass index (BMI) must be between 18 and 32, and you must weigh less than 120 kg.
  • You need to be generally healthy, with no major illnesses.
  • You must agree to use contraception if you or your partner can get pregnant.
  • You must be able to swallow tablets without difficulty.
  • You must not have taken certain medications or herbal supplements in the past 14 days.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07285967Not yet recruiting· Phase 1
First-in-human study of YR011 tablet in healthy volunteers

This study tests a new oral medication called YR011 for the first time in people. It aims to find a safe dose and see how the body handles it, which may help treat future conditions.

NCT07674940Recruiting· Phase 1
Study of a new drug at different doses in healthy people

This trial tests different doses of a new study drug in healthy people to see how safe it is and how the body handles it. Participation involves taking the drug and having regular check-ups.

Miramar, Florida
NCT07748702Not yet recruiting· Phase 1
Study of a new drug in healthy volunteers

This trial tests a new medicine (CKD-339) in healthy people to see how the body processes it and if it is safe. It is an early-stage study that could help develop a treatment for conditions like high blood pressure or heart problems.

Seoul
NCT07143331Not yet recruiting· Phase 1
Testing a new medicine for safety in healthy volunteers

This study tests a new medicine called KS101 to see if it is safe and how it works in healthy people for the first time. It is a first-in-human trial, meaning this is the first time the drug is given to people, and your health will be closely monitored throughout.

Sydney, New South Wales
NCT07640438Recruiting· Phase 1
Safety Study of New Drug in Healthy Adults

This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.

Hangzhou, Zhejiang
NCT07813663Not yet recruiting· Phase 1
Safety study of an experimental oral drug in healthy adults

This study tests a new oral investigational drug in healthy adults to see how safe it is and how the body handles it. It is an early-phase trial that helps determine the right dose and check for side effects.

Hear when a new Safety trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.